Search Results

There are 25989 results for: content related to: High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy

  1. Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 12, December 2012, Pages: 2209–2217, Casper Steenholdt, Magid Al-khalaf, Jørn Brynskov, Klaus Bendtzen, Ole Ø. Thomsen and Mark A. Ainsworth

    Version of Record online : 16 FEB 2012, DOI: 10.1002/ibd.22910

  2. You have free access to this content
    Antitumor necrosis factor treatment for pediatric inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 5, May 2012, Pages: 985–1002, Charlotte I. de Bie, Johanna C. Escher and Lissy de Ridder

    Version of Record online : 20 SEP 2011, DOI: 10.1002/ibd.21871

  3. Monitoring functional serum antitumor necrosis factor antibody level in Crohn's disease patients who maintained and those who lost response to anti-TNF

    Inflammatory Bowel Diseases

    Volume 16, Issue 11, November 2010, Pages: 1898–1904, Akihiro Yamada, Koji Sono, Nobuo Hosoe, Nobuo Takada and Yasuo Suzuki

    Version of Record online : 22 MAR 2010, DOI: 10.1002/ibd.21259

  4. Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies

    Inflammatory Bowel Diseases

    Volume 18, Issue 9, September 2012, Pages: 1628–1633, Uri Kopylov, Yoav Mazor, Miri Yavzori, Ella Fudim, Lior Katz, Daniel Coscas, Orit Picard, Yehuda Chowers, Rami Eliakim and Shomron Ben-Horin

    Version of Record online : 29 OCT 2011, DOI: 10.1002/ibd.21919

  5. You have free access to this content
    Pre-existing IgG antibodies cross-reacting with the Fab region of infliximab predict efficacy and safety of infliximab therapy in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 12, June 2013, Pages: 1172–1183, C. Steenholdt, Y. Palarasah, K. Bendtzen, A. Teisner, J. Brynskov, B. Teisner and C. H. Nielsen

    Version of Record online : 7 MAY 2013, DOI: 10.1111/apt.12330

  6. Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: A population-based study

    Inflammatory Bowel Diseases

    Volume 17, Issue 10, October 2011, Pages: 2144–2152, Valérie Crombé, Julia Salleron, Guillaume Savoye, Jean-Louis Dupas, Gwénola Vernier-Massouille, Eric Lerebours, Antoine Cortot, Véronique Merle, Francis Vasseur, Dominique Turck, Corinne Gower-Rousseau, Marc Lémann, Jean-Frédéric Colombel and Alain Duhamel

    Version of Record online : 1 FEB 2011, DOI: 10.1002/ibd.21615

  7. You have free access to this content
    Protection from articular damage by passive or active anti-tumour necrosis factor (TNF)-α immunotherapy in human TNF-α transgenic mice depends on anti-TNF-α antibody levels

    Clinical & Experimental Immunology

    Volume 172, Issue 1, April 2013, Pages: 54–62, L. Semerano, J. Biton, L. Delavallée, E. Duvallet, E. Assier, N. Bessis, E. Bernier, O. Dhellin, G. Grouard-Vogel and M.-C. Boissier

    Version of Record online : 10 MAR 2013, DOI: 10.1111/cei.12040

  8. A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone

    British Journal of Dermatology

    Volume 172, Issue 3, March 2015, Pages: 760–768, R.P. Hall III, J. Fairley, D. Woodley, V.P. Werth, D. Hannah, R.D. Streilein, J. McKillip, J. Okawa, M. Rose, L.L. Keyes-Elstein, A. Pinckney, A. Overington, J. Wedgwood, L. Ding and B. Welch

    Version of Record online : 5 FEB 2015, DOI: 10.1111/bjd.13350

  9. Comparison of medical costs among patients using adalimumab and infliximab: A retrospective study (COMPAIRS)

    Inflammatory Bowel Diseases

    Volume 18, Issue 11, November 2012, Pages: 2043–2055, Daniel A. Sussman, Nisa Kubiliun, Parvez M. Mulani, Jingdong Chao, Carol A.T. Gillis, Mei Yang, Mei Lu and Maria T. Abreu

    Version of Record online : 12 JAN 2012, DOI: 10.1002/ibd.22873

  10. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 5, May 2010, Pages: 886–891, Shuji Yamamoto, Hiroshi Nakase, Minoru Matsuura, Yusuke Honzawa, Satohiro Masuda, Ken-ichi Inui and Tsutomu Chiba

    Version of Record online : 7 DEC 2009, DOI: 10.1111/j.1440-1746.2009.06206.x

  11. You have free access to this content
    Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 1, July 2011, Pages: 51–58, C. Steenholdt, M. Svenson, K. Bendtzen, O. Ø. Thomsen, J. Brynskov and M. A. Ainsworth

    Version of Record online : 3 MAY 2011, DOI: 10.1111/j.1365-2036.2011.04682.x

  12. You have free access to this content
    The duration of effect of infliximab maintenance treatment in paediatric Crohn’s disease is limited

    Alimentary Pharmacology & Therapeutics

    Volume 33, Issue 2, January 2011, Pages: 243–250, C. I. De Bie, T. Z. Hummel, A. Kindermann, F. T. M. Kokke, G. M. Damen, C. M. F. Kneepkens, P. F. Van Rheenen, J. J. Schweizer, J. H. Hoekstra, O. F. Norbruis, W. E. Tjon a Ten, A. C. Vreugdenhil, J. M. Deckers-Kocken, C. F. M. Gijsbers, J. C. Escher and L. De Ridder

    Version of Record online : 14 NOV 2010, DOI: 10.1111/j.1365-2036.2010.04507.x

  13. Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: A 3-year prospective randomized open trial

    Inflammatory Bowel Diseases

    Volume 18, Issue 9, September 2012, Pages: 1617–1623, Koji Yoshida, Ken Fukunaga, Hiroki Ikeuchi, Koji Kamikozuru, Nobuyuki Hida, Yoshio Ohda, Yoko Yokoyama, Masaki Iimuro, Naohisa Takeda, Kyoichi Kato, Risa Kikuyama, Kazuko Nagase, Kazutoshi Hori, Shiro Nakamura, Hiroto Miwa and Takayuki Matsumoto

    Version of Record online : 13 NOV 2011, DOI: 10.1002/ibd.21928

  14. You have free access to this content
    Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 8, October 2012, Pages: 765–771, N. Vande Casteele, D. J. Buurman, M. G. G. Sturkenboom, J. H. Kleibeuker, S. Vermeire, T. Rispens, D. van der Kleij, A. Gils and G. Dijkstra

    Version of Record online : 28 AUG 2012, DOI: 10.1111/apt.12030

  15. You have free access to this content
    Infliximab improves inflammation and anthropometric measures in pediatric Crohn's disease

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 4, April 2010, Pages: 810–816, Daniel M Sinitsky, Daniel A Lemberg, Steven T Leach, Timothy D Bohane, Reuben Jackson and Andrew S Day

    Version of Record online : 24 NOV 2009, DOI: 10.1111/j.1440-1746.2009.06195.x

  16. Comparison of efficacy, pharmacokinetics, and immunogenicity between infliximab mono- versus combination therapy in ulcerative colitis

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 6, June 2014, Pages: 1177–1185, Michael J Hayes, Adam C Stein and Atsushi Sakuraba

    Version of Record online : 15 MAY 2014, DOI: 10.1111/jgh.12517

  17. Predictors of early response to infliximab in patients with ulcerative colitis

    Inflammatory Bowel Diseases

    Volume 13, Issue 2, February 2007, Pages: 123–128, Marc Ferrante, Séverine Vermeire, Konstantinos H. Katsanos, Maja Noman, Gert Van Assche, Fabian Schnitzler, Ingrid Arijs, Gert De Hertogh, Ilse Hoffman, Karel Geboes and Paul Rutgeerts

    Version of Record online : 19 DEC 2006, DOI: 10.1002/ibd.20054

  18. You have free access to this content
    Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 5, September 2013, Pages: 447–459, R. Khanna, B. D. Sattin, W. Afif, E. I. Benchimol, E.-J. Bernard, A. Bitton, B. Bressler, R. N. Fedorak, S. Ghosh, G. R. Greenberg, J. K. Marshall, R. Panaccione, E. G. Seidman, M. S. Silverberg, A. H. Steinhart, R. Sy, G. Van Assche, T. D. Walters, W. J. Sandborn and B. G. Feagan

    Version of Record online : 14 JUL 2013, DOI: 10.1111/apt.12407

  19. You have free access to this content
    Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 5, March 2012, Pages: 562–567, E. Rostholder, A. Ahmed, A. S. Cheifetz and A. C Moss

    Version of Record online : 13 JAN 2012, DOI: 10.1111/j.1365-2036.2011.04986.x

  20. You have free access to this content
    eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 9, November 2012, Pages: 840–849, N. Pedersen, M. Elkjaer, D. Duricova, J. Burisch, C. Dobrzanski, N. N. Andersen, T. Jess, F. Bendtsen, E. Langholz, S. Leotta, T. Knudsen, N. Thorsgaard and P. Munkholm

    Version of Record online : 12 SEP 2012, DOI: 10.1111/apt.12043